Embed Size (px)
Citation preview
Estonian Biotechnology
Sector - insights
Sven Parkel, PhD
Ostrawa 2016
My background
PhD in Bioorganic Chemistry
University of Tartu
Connected Health Estonia cluster
Startups
Sector analysis for the Estonian Development Fund
Why biotech / healthtech?
One of the fastest growing industries
High added value
Creates jobs in other sectors.
Creates additional indirect and induced economic activity
Above average salaries
Recreates the workers’ health thus reduces costs for the economy
Centar
Added value prediction
Value added (million EUR) Share of private sector (%)
year year
Number of workers Share of workers in private sector (%)
Value added per worker (EUR) Value added per worker compared
to private sector average
Export (million EUR) Share of export in revenue (%)
Support measures (million EUR) Share of the support in value added (%)
Biotech is like decathlon
a strong science base
• supportive entrepreneurial culture
• a growing company base
• the ability to attract key staff
• the availability of financing
• appropriate premises and R&D infrastructure
• the close proximity of business support services and large companies in related industries
• a skilled workforce
• effective networks (for example, associations and cluster councils)
• supportive (national, regional and local) government policies
BIOTECHNOLOGY CLUSTERS, Minister for Science UK, 1999
Strong science base
Entrepre
neurial
culture
Growing
company
base
Ability
to
attract
key staff
Appropriate
premises and
infrastructure
Skilled
workforce
Large
company
Availability
of
financing
Effective
networks
Supportive
policies
Strong science
R & D expenses (2013)
%GDP million EUR scientists per 1000 inhabitants
Estonia 1,74 389 7,33
Latvia 0,8 235 3,1 (2009)
Lithuania 1,01 (2014) 443
University of Tartu – the only Baltic university in
top3% in Times Higher Education list.
Two best Baltic universities by QS World
University Rankings are in Estonia
Estonian Development Fund, Smart Specialization report
(talent pool and) ability to attract key
staff
Top level scientists returning or coming to Estonia
Number of businessmen, coaches and mentors with sector
experience
Number of PhD holders in private sector
appropriate premises and R&D
infrastructure
Laboratory space used for entrepreneurial activities,
turnover of commercialization activities
testbeds
Competence Centres, Institutes, Universities
Private R&D organization
the proximity of business support services
and large companies (in related industries)
Number of large companies
Number of support service providers – lawyers,
accountants, HR, etc
availability of financing
Number of experienced investors
Proof-of-Concept funding
Financing the technology development (beyond PoC)
Venture capital, foreign capital, deals with large biotech/pharma
companies
supportive entrepreneurial culture
Number and size of the sector companies - 50 companies and 300 workers
PhD holders with relevant business experience, experiencedbusinessmen with sector specific competences
R&D collaboration between companies and R&D institutes
University spin-offs, entrepreneurship programs, scolarshipswith entrepreneurs
Quality and quantity - match between the needs of entrepreneurs and skills of graduants
effective networks
Synchrony between different ecosystem parts:
Networks for every company / startup phase
Number of new partners, development potential and openness
• Member of European Connected Health Association
• All healthtech related universities
• ~40 companies in different development phases (mostly ICT)
supportive (national, regional and local)
government policies
National programme (Estonian Biotechnology Programme 2010-2013)
Taxes – relief for R&D activities
a growing company base .....
Number of ideas and startups (by different phases)
Number and value of exits
Raised capital
Revenue and turnover of the sector
Number of job positions
Export?
Strong science base
Entrepre
neurial
culture
Growing
company
base
Ability
to
attract
key staff
Appropriate
premises and
infrastructure
Skilled
workforce
Large
company
Availability
of
financing
Effective
networks
Supportive
policies
Pre-launch Startup phase
Financial need
Profit/Loss
Science Preparation Startup Early phase GrowthMarket access
Basic science.
No vision for a
company, no
team.
Proof-of-
concept, IP
evaluation,
patenting. R&D
and targeted
financing. First
ideas about the
potential,
business plan
and model.
Finding team
members.
Company
registration, team
formation. R&D
acitivities.
Adjusting business
plan and model.
Negotiations with
regulatory organs,
partners, etc. First
product(s). New
patent
applications
Product testing,
discussions with
regulatory
organs.
Describing and
fine-tuning the
product. Finding
partners.
Market entry,
finding
partners,
sales.
Feedback
from the
market, users.
Establishing
market share,
selling, growing
Estonian Development Fund, Smart Specialization report
Technology Transfer Unit
What we offer
Access to...
services – from analysis and measurement to in depth consultation and training
students – workforce with potential
infrastructure – from world class equipment to state-of-the-art facilities
research – let us solve your problems
technology – the next leap in progress
Estonian Biopank / Genome Center
Contains over 50 000 general population samples – 5% of Estonian population
Medical history and current health status is recorded according to ICD10
codes, medication according to ATC
Can be linked to Estonian eHealth system
18 scientific collaboration projects with foreign partners
70 publications
Functional food and supplementsInstitute of Microbiology and Institute of Biochemistry combine their
know-how in offering innovative solutions to food and food supplement
companies.
Unique patented lactic acid bacteria L. fermentum ME-3 is strong
natural antioxidant suitable for different products containing dairy, vegan
milk, chocolate or vitamins, minerals and other active substances.
Extensive collection of other beneficial strains.
Long-term experience with Maitokolmio (FI), Raisio (FI), L’allemand (FR),
VF Bioscience – Reg’Activ products (FR)), licenses available.
Thank you!
Sven Parkel, PhDTechnology Transfer OfficerOffice of Research and DevelopmentUniversity of Tartu,Lossi 3-323, 51003 TartuESTONIA
Phone: (+372) 5663 5577
